Guy W. Scadding

3.1k total citations
44 papers, 1.5k citations indexed

About

Guy W. Scadding is a scholar working on Immunology and Allergy, Physiology and Dermatology. According to data from OpenAlex, Guy W. Scadding has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Immunology and Allergy, 31 papers in Physiology and 20 papers in Dermatology. Recurrent topics in Guy W. Scadding's work include Allergic Rhinitis and Sensitization (35 papers), Asthma and respiratory diseases (30 papers) and Dermatology and Skin Diseases (13 papers). Guy W. Scadding is often cited by papers focused on Allergic Rhinitis and Sensitization (35 papers), Asthma and respiratory diseases (30 papers) and Dermatology and Skin Diseases (13 papers). Guy W. Scadding collaborates with scholars based in United Kingdom, United States and Italy. Guy W. Scadding's co-authors include Stephen R. Durham, Mohamed H. Shamji, Glenis Scadding, Deborah Phippard, Aarif O. Eifan, Alkis Togias, Janice A. Layhadi, Mikila R. Jacobson, Kayhan T. Nouri‐Aria and Moisés A. Calderón and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, The British Journal of Psychiatry and European Respiratory Journal.

In The Last Decade

Guy W. Scadding

42 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guy W. Scadding United Kingdom 22 1.1k 1.0k 517 259 137 44 1.5k
Caterina Pronzato Italy 14 836 0.8× 833 0.8× 271 0.5× 108 0.4× 246 1.8× 26 1.0k
Robert M. Naclerio United States 18 988 0.9× 1.0k 1.0× 227 0.4× 229 0.9× 338 2.5× 27 1.4k
E. Rijntjes Netherlands 19 662 0.6× 639 0.6× 131 0.3× 205 0.8× 268 2.0× 28 983
R. M. Naclerio United States 16 540 0.5× 628 0.6× 100 0.2× 321 1.2× 188 1.4× 33 1.1k
Atsushi Yuta Japan 17 324 0.3× 426 0.4× 83 0.2× 175 0.7× 252 1.8× 78 942
F.A. Romero United States 10 286 0.3× 420 0.4× 53 0.1× 117 0.5× 222 1.6× 21 573
J. Christian Virchow Germany 12 250 0.2× 718 0.7× 67 0.1× 375 1.4× 312 2.3× 17 921
S. Oddera Italy 18 229 0.2× 602 0.6× 46 0.1× 269 1.0× 417 3.0× 42 958
Melody C. Carter United States 22 981 0.9× 408 0.4× 137 0.3× 1.1k 4.3× 68 0.5× 46 1.6k

Countries citing papers authored by Guy W. Scadding

Since Specialization
Citations

This map shows the geographic impact of Guy W. Scadding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy W. Scadding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy W. Scadding more than expected).

Fields of papers citing papers by Guy W. Scadding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy W. Scadding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy W. Scadding. The network helps show where Guy W. Scadding may publish in the future.

Co-authorship network of co-authors of Guy W. Scadding

This figure shows the co-authorship network connecting the top 25 collaborators of Guy W. Scadding. A scholar is included among the top collaborators of Guy W. Scadding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy W. Scadding. Guy W. Scadding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kouranos, Vasileios, Stephen R. Durham, Guy W. Scadding, et al.. (2024). JAK‐inhibitor Tofacitinib in Severe Laryngeal Sarcoidosis: A Case Report. The Laryngoscope. 135(2). 829–832. 1 indexed citations
2.
Altman, Matthew C., R. Max Segnitz, David Larson, et al.. (2023). Nasal and blood transcriptomic pathways underpinning the clinical response to grass pollen immunotherapy. Journal of Allergy and Clinical Immunology. 152(5). 1247–1260. 10 indexed citations
3.
Gauvreau, Gail M., Beth E. Davis, Guy W. Scadding, et al.. (2022). Allergen provocation tests in respiratory research: building on 50 years of experience. European Respiratory Journal. 60(2). 2102782–2102782. 19 indexed citations
4.
Scadding, Glenis, et al.. (2021). Innate and Adaptive Immunity: ILC2 and Th2 Cells in Upper and Lower Airway Allergic Diseases. The Journal of Allergy and Clinical Immunology In Practice. 9(5). 1851–1857. 43 indexed citations
5.
Scadding, Guy W.. (2021). Real world evidence of long-term benefits from allergen-specific immunotherapy (AIT). The Lancet Regional Health - Europe. 13. 100283–100283. 5 indexed citations
6.
Shamji, Mohamed H., David Larson, Aarif O. Eifan, et al.. (2021). Differential induction of allergen-specific IgA responses following timothy grass subcutaneous and sublingual immunotherapy. Journal of Allergy and Clinical Immunology. 148(4). 1061–1071.e11. 66 indexed citations
7.
Marone, Giancarlo, Francescopaolo Granata, Valentina Pucino, et al.. (2019). The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma. Frontiers in Pharmacology. 10. 1387–1387. 128 indexed citations
8.
Shamji, Mohamed H., Janice A. Layhadi, Daniela Achkova, et al.. (2018). Role of IL-35 in sublingual allergen immunotherapy. Journal of Allergy and Clinical Immunology. 143(3). 1131–1142.e4. 86 indexed citations
9.
Penagos, Martín, Aarif O. Eifan, Stephen R. Durham, & Guy W. Scadding. (2018). Duration of Allergen Immunotherapy for Long-Term Efficacy in Allergic Rhinoconjunctivitis. Current Treatment Options in Allergy. 5(3). 275–290. 51 indexed citations
10.
Scadding, Glenis, et al.. (2016). Diagnosing Allergic Rhinitis. Immunology and Allergy Clinics of North America. 36(2). 249–260. 14 indexed citations
11.
Bachert, Claus, Giorgio Walter Canonica, Joaquim Mullol, et al.. (2015). MP29-02*'s advanced delivery system contributes to its efficacy in patients with moderate/severe seasonal allergic rhinitis. Allergy. 70. 504–505. 3 indexed citations
12.
Chaker, Adam, Mohamed H. Shamji, Moisés A. Calderón, et al.. (2015). Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti–IL-4: A randomized controlled trial. Journal of Allergy and Clinical Immunology. 137(2). 452–461.e9. 45 indexed citations
13.
Scadding, Guy W.. (2014). Cytokine Profiles in Allergic Rhinitis. Current Allergy and Asthma Reports. 14(5). 435–435. 65 indexed citations
14.
Shamji, Mohamed H., Janice A. Layhadi, Guy W. Scadding, et al.. (2014). Basophil expression of diamine oxidase: A novel biomarker of allergen immunotherapy response. Journal of Allergy and Clinical Immunology. 135(4). 913–921.e9. 88 indexed citations
15.
Makatsori, Melina, Guy W. Scadding, Isabel Skypala, & Stephen R. Durham. (2014). Silk contact anaphylaxis. Contact Dermatitis. 71(5). 314–315. 8 indexed citations
16.
Scadding, Guy W., Aarif O. Eifan, Martín Penagos, et al.. (2013). Grass pollen nasal challenge is associated with increases in Th2 cytokines, Eotaxin, MDC and IL‐6 in nasal fluid. Clinical and Translational Allergy. 3(S2). 2 indexed citations
17.
Hellings, Peter W., Guy W. Scadding, Isam Alobid, et al.. (2012). Executive summary of European Task Force document on diagnostic tools in rhinology. Rhinology Journal. 50(4). 339–352. 49 indexed citations
18.
Scadding, Guy W. & Stephen R. Durham. (2011). Mechanisms of Sublingual Immunotherapy. Immunology and Allergy Clinics of North America. 31(2). 191–209. 20 indexed citations
19.
Banfield, G., Hiroshi Watanabe, Guy W. Scadding, et al.. (2010). CC Chemokine Receptor 4 (CCR4) in human allergen‐induced late nasal responses. Allergy. 65(9). 1126–1133. 40 indexed citations
20.
Scadding, Guy W. & Stephen R. Durham. (2009). Mechanisms of Sublingual Immunotherapy. Journal of Asthma. 46(4). 322–334. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026